Reproductive endocrinology. Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women

By Fowler Paul A.  

Human Reproduction, Vol. 16, Iss. 7, 2001-07 ,pp. : 1353-1358

Oxford University Press

Access to resources Recommend Favorite

Puberty, ageing and hormone replacement therapy. The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study

By Wahab May  

Human Reproduction, Vol. 17, Iss. 5, 2002-05 ,pp. : 1386-1390

Oxford University Press

Access to resources Recommend Favorite

Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations

By Bernardi F  

Human Reproduction, Vol. 13, Iss. 2, 1998-02 ,pp. : 279-284

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluid

By Pappa Aglaia  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1449-1456

Oxford University Press

Access to resources Recommend Favorite

The recombinant subdomain IIIB of human serum albumin displays activity of gonadotrophin surge‐attenuating factor

By Tavoulari Sotiria  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 849-858

Oxford University Press

Access to resources Recommend Favorite